Litcius/Paper detail

Combined Central Retinal Artery and Vein Occlusion with Ischemic Optic Neuropathy After COVID-19 Vaccination

Sol Lee, Kamlesh K Sankhala, Swaraj Bose, Ron P Gallemore

2022International Medical Case Reports Journal25 citationsDOIOpen Access PDF

Abstract

PURPOSE: To report a case of combined central retinal vein and artery occlusion that evolved into ischemic optic neuropathy following the Pfizer COVID-19 vaccination. METHODS: Patient was followed with optical coherence tomography (OCT), fluorescein angiography, and Humphrey visual field. RESULTS: Patient was able to recover vision from count fingers to 20/30 on a combination of aflibercept, steroidal and non-steroidal anti-inflammatories, a diuretic (acetazolamide), antiplatelet agents (aspirin and pentoxifylline), and an anticoagulant (apixaban). CONCLUSION: COVID-19 vaccination may be associated with a myriad of sight-threatening ocular thrombotic conditions, which may respond to a combination of anti-inflammatory and anticoagulant therapies.

Topics & Concepts

MedicineCentral retinal arteryCentral retinal artery occlusionCentral retinal veinIschemic optic neuropathyCentral retinal vein occlusionOptic neuropathyOphthalmologyVaccinationOcclusionRetinal Artery OcclusionRetinalAnticoagulantCardiologyIschemic strokeSurgeryAnticoagulant therapyCentral scotomaIschemiaOptic nerveInternal medicineMacular degenerationRetinaAnterior ischemic optic neuropathyOphthalmic arteryVeinArteryCiliary arteriesRadiologyRetinal and Optic ConditionsHeparin-Induced Thrombocytopenia and ThrombosisIntraoperative Neuromonitoring and Anesthetic Effects
Combined Central Retinal Artery and Vein Occlusion with Ischemic Optic Neuropathy After COVID-19 Vaccination | Litcius